当前位置: X-MOL 学术Mol. Psychiatry › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
Molecular Psychiatry ( IF 9.6 ) Pub Date : 2018-Nov-01 , DOI: 10.1038/mp.2017.156
C Greene 1 , J Kealy 1 , M M Humphries 1 , Y Gong 2 , J Hou 2 , N Hudson 1 , L M Cassidy 1 , R Martiniano 1 , V Shashi 3 , S R Hooper 4 , G A Grant 5 , P F Kenna 1 , K Norris 6 , C K Callaghan 7, 8 , M dN Islam 7, 8 , S M O'Mara 7, 8 , Z Najda 1 , S G Campbell 6 , J S Pachter 9 , J Thomas 10 , N M Williams 10 , P Humphries 1 , K C Murphy 11 , M Campbell 1
Affiliation  

Schizophrenia is a neurodevelopmental disorder that affects up to 1% of the general population. Various genes show associations with schizophrenia and a very weak nominal association with the tight junction protein, claudin-5, has previously been identified. Claudin-5 is expressed in endothelial cells forming part of the blood-brain barrier (BBB). Furthermore, schizophrenia occurs in 30% of individuals with 22q11 deletion syndrome (22q11DS), a population who are haploinsufficient for the claudin-5 gene. Here, we show that a variant in the claudin-5 gene is weakly associated with schizophrenia in 22q11DS, leading to 75% less claudin-5 being expressed in endothelial cells. We also show that targeted adeno-associated virus-mediated suppression of claudin-5 in the mouse brain results in localized BBB disruption and behavioural changes. Using an inducible 'knockdown' mouse model, we further link claudin-5 suppression with psychosis through a distinct behavioural phenotype showing impairments in learning and memory, anxiety-like behaviour and sensorimotor gating. In addition, these animals develop seizures and die after 3-4 weeks of claudin-5 suppression, reinforcing the crucial role of claudin-5 in normal neurological function. Finally, we show that anti-psychotic medications dose-dependently increase claudin-5 expression in vitro and in vivo while aberrant, discontinuous expression of claudin-5 in the brains of schizophrenic patients post mortem was observed compared to age-matched controls. Together, these data suggest that BBB disruption may be a modifying factor in the development of schizophrenia and that drugs directly targeting the BBB may offer new therapeutic opportunities for treating this disorder.

中文翻译:

Claudin-5 的剂量依赖性表达是精神分裂症的调节因子。

精神分裂症是一种神经发育障碍,影响高达 1% 的普通人群。各种基因显示出与精神分裂症的关联,并且与紧密连接蛋白 claudin-5 的名义关联非常弱,此前已被确定。Claudin-5 在形成血脑屏障 (BBB) 一部分的内皮细胞中表达。此外,精神分裂症发生在 30% 的 22q11 缺失综合征 (22q11DS) 个体中,这是一个 claudin-5 基因单倍体不足的人群。在这里,我们显示 claudin-5 基因中的一个变体与 22q11DS 中的精神分裂症弱相关,导致内皮细胞中表达的 claudin-5 减少了 75%。我们还表明,靶向腺相关病毒介导的小鼠大脑中 claudin-5 的抑制会导致局部 BBB 破坏和行为改变。使用可诱导的“击倒”小鼠模型,我们通过显示学习和记忆、焦虑样行为和感觉运动门控障碍的独特行为表型进一步将 Claudin-5 抑制与精神病联系起来。此外,这些动物在 claudin-5 抑制 3-4 周后出现癫痫发作并死亡,这加强了 claudin-5 在正常神经功能中的关键作用。最后,我们发现抗精神病药物在体外和体内呈剂量依赖性地增加 claudin-5 的表达,而与年龄匹配的对照组相比,在精神分裂症患者死后的大脑中观察到 claudin-5 的异常、不连续表达。一起,
更新日期:2017-10-11
down
wechat
bug